Before a new tobacco product can legally enter the market in any country, a formal application must be reviewed and approved by that country’s regulatory body. For example, in countries like the USA, the Food and Drug Administration (FDA) will review all premarket tobacco product applications (PTPA), but these applications are usually required to be accompanied by a list of supportive documents that include reports and research on tobacco harm reduction.

“While PTPA can be submitted by anyone or any manufacturer seeking an FDA marketing order for a new tobacco product, compliance with the premarket tobacco product applications is truly challenging, because of the format requirements and importance of including research,” said Sophie Notley. She is a researcher from CSURES in Glasgow UK – an independent research centre that focuses on behavioural science in tobacco harm reduction – and added that “CSURES can provide regulatory submission assistance to anyone that seeks marketing authorization.”

The highly qualified research team from CSURES specialises in design and execution of research programs, to meet the compliance demands established by regulators for PMTA and MRTP submissions, but they also provide analytical research and offer professional presentation of research findings. The research topics covered by their team of experts serves as an important instrument in the proper regulation of tobacco products, and their research work aids in efforts made to reduce tobacco harm.

As proponents of reducing tobacco harm, CSURES conducts research and provides data on the reduction of health risks for the individual user and suggests that the availability of safer alternatives or initiatives to the smoking of tobacco products, should be associated with reduced smoking or smoking cessation. Damage reduction initiatives can range between anything from warnings on the packaging of tobacco products to cigarettes with lower tar content and filters.

Electronic cigarettes may be a promising technology for reducing damage, and its regulation varies around the world, but it does not mean that when you want to make a new e-cigarette product available to the market, that you do not have to submit the necessary premarket tobacco product application. However, CSURES can be of valuable assistance when it comes to any premarket tobacco product application.
CSUR has many areas of expertise and a selection of their past and current research, is contained in their website. They also offer a complete range of services and it you want to learn more about the agency and the work they do, you can visit their website, or send them an email.

About us: CSUR is a Global Leader on Behavioural Science in Tobacco Harm Reduction, operating from their base at the Centre for Substance Use Research Ltd in Glasgow. CSUR opened in 1994 linked initially to the University of Glasgow, and in 2011 CSUR became a wholly independent research centre focussing on a wider range of substance use issues and developing a large programme of behaviourally focussed regulatory science research assessing the contribution of ENDS in reducing tobacco-related health harm. Our team comprises post-doctoral researchers in behavioural science, experts in marketing, cybersecurity, and media. Our focus is on furthering the goals of tobacco-related harm reduction and assessing the public health impact of Electronic Nicotine Delivery Systems (ENDS) and our goal is to ensure that those working within these industries have access to high-quality behavioural research that can further their owns goals of reducing the harms associated with the use of combustible tobacco products. Find out more by visiting our website at https://www.csures.com.